Chinese biotech firm claims anti-aging pill could extend lifespan

A Chinese biotechnology company has sparked global interest after claiming that an experimental anti-aging pill could one day help humans live up to 150 years, although scientists stress that such claims have not yet been proven in people.

Shenzhen-based Lonvi Biosciences is developing a capsule containing Procyanidin C1 (PCC1), a natural compound derived from grape seed extract.

Researchers believe the substance may help combat aging by targeting senescent cells, often referred to as “zombie cells.”

These cells stop dividing as they age but remain inside the body, where they can contribute to inflammation, tissue damage, and various age-related diseases.

Scientists have increasingly focused on removing or controlling such cells as a possible way to improve health and extend lifespan.

The company says PCC1 could become part of a broader strategy to slow biological aging and improve quality of life in older adults.

It has suggested that significantly longer lifespans, potentially reaching 150 years, may become achievable in the future.

Read Also:Pakistani doctor creates AI chatbot to detect skin cancer

However, experts caution that the evidence remains limited. Much of the research supporting PCC1 comes from animal studies rather than human trials.

A study published in 2021 found that PCC1 improved health and extended lifespan in mice by reducing the harmful effects of senescent cells.

Medical researchers note that promising results in animals do not automatically translate into success in humans. Large-scale clinical trials will be required before any claims about life extension can be scientifically verified.

The announcement reflects growing global investment in longevity science, as researchers increasingly explore treatments that target the aging process itself rather than individual diseases.

For now, the anti-aging pill remains an experimental product awaiting further scientific validation.